Figure 1 (IMAGE)

Compuscript Ltd

Figure 1

Caption

SHP2-mediated tumor immunosuppression in colon cancer was defined by scRNA-seq. SHP2 negatively regulates type I interferon signaling. SHP2 allosteric inhibition remolds the anti-tumor TME, indicating SHP2 is a promising target for colon cancer immunotherapy.

Credit

APSB

Usage Restrictions

No restrictions.

License

Public Domain

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.